Clinical Trial Update: Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating boceprevir in adults with chronic hepatitis C genotype 1 who failed prior peginterferon/ribavirin therapy has been completed, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2011-06-15